project id: TCGA-GBM; case submitter id: TCGA-76-6286; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 60; days to birth: -22173; days to death: 638; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1949; year of death: 2010; age at diagnosis: 22173; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 638.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; intermediate dimension: 0.3; longest dimension: 0.4; preservation method: Unknown; shortest dimension: 0.2; sample id: 8bf9c2af-882b-46d7-bbf3-3b00ae887c47; sample submitter id: TCGA-76-6286-01A; portion id: 0ad2d1fe-87b2-458f-8ac1-06884e71ed5c; portion submitter id: TCGA-76-6286-01A-11; slide id: 68048529-8f03-4641-a821-3fa49c22a5fd; slide submitter id: TCGA-76-6286-01A-01-TS1; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0; section location: TOP;